Your browser doesn't support javascript.
loading
Identification of DDIT4 as a potential prognostic marker associated with chemotherapeutic and immunotherapeutic response in triple-negative breast cancer.
Chen, Xuanzhao; Li, Zeyan; Liang, Meihua; Zhang, Ziyang; Zhu, Di; Lin, Biyun; Zhou, Renyu; Lu, Yuanzhi.
Afiliación
  • Chen X; The Center of Pathological Diagnosis and Research, Affiliated Hospital of Guangdong Medical University, Zhanjiang, China.
  • Li Z; Renmin Hospital of Wuhan University, Wuhan, Hubei, China.
  • Liang M; The Center of Pathological Diagnosis and Research, Affiliated Hospital of Guangdong Medical University, Zhanjiang, China.
  • Zhang Z; Guangzhou Huayin Medical Laboratory Center, Ltd., Guangzhou, China.
  • Zhu D; Department of Clinical Pathology, First Affiliated Hospital of Jinan University, Guangzhou, China.
  • Lin B; The Center of Pathological Diagnosis and Research, Affiliated Hospital of Guangdong Medical University, Zhanjiang, China.
  • Zhou R; School of Medicine, Jinan University, Guangzhou, China.
  • Lu Y; The Center of Pathological Diagnosis and Research, Affiliated Hospital of Guangdong Medical University, Zhanjiang, China. yuanzhi.lu@jnu.edu.cn.
World J Surg Oncol ; 21(1): 194, 2023 Jun 30.
Article en En | MEDLINE | ID: mdl-37391802

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama Triple Negativas Tipo de estudio: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama Triple Negativas Tipo de estudio: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article